"10.1371_journal.pone.0113034","plos one","2014-12-01T00:00:00Z","Christina Sølund; Henrik Krarup; Santseharay Ramirez; Peter Thielsen; Birgit T Røge; Suzanne Lunding; Toke S Barfod; Lone G Madsen; Britta Tarp; Peer B Christensen; Jan Gerstoft; Alex L Laursen; Jens Bukh; Nina Weis; The DANHEP group","Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases and Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark; and Department of International Health, Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Section of Molecular Diagnostics, Clinical Biochemistry and Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark; Department of Medicine, Kolding Hospital, Kolding, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Hillerød, Denmark; Department of Infectious Diseases, Roskilde Hospital, Roskilde, Denmark; Department of Gastroenterology, Køge Hospital, Køge, Denmark; Diagnostic Center, Silkeborg Regional Hospital, Silkeborg, Denmark; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark","Conceived and designed the experiments: NW JB CS SR HK. Performed the experiments: CS SR HK. Analyzed the data: NW JB CS SR. Contributed reagents/materials/analysis tools: CS SR HK PT BR BT SL JG PC AL LM TB JB NW. Wrote the paper: CS SR HK PT BR BT SL JG PC AL LM TB JB NW.","Nina Weis has been a member of advisory boards for Bristol Myers Squibb, Gilead, Glaxo Smith Kline, Janssen and Merck Sharp & Dohme and investigator for Bristol Myers Squibb, Merck Sharp & Dohme and Janssen. Alex Lund Laursen has been member of advisory boards for Bristol Myers Squibb, Gilead, Glaxo Smith Kline, Merck Sharp & Dome and Janssen and been investigator for clinical trials for Bristol Myers Squibb and Merck Sharp & Dohme. Jan Gerstoft has been a member of advisory boards, received grants from or served as an investigator for Bristol Myers Squibb, Gilead, Glaxo Smith Kline, Merck Sharp & Dome, Medivir, Abbvie and Janssen. Lone G. Madsen has been a member of advisory boards for Glaxo Smith Kline. Peer Brehm Christensen has been investigator for Abbvie, Bristol Myers Squibb, Janssen and Merck Sharp & Dohme. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The following authors declare no conflicts of interest: Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T. Røge, Suzanne Lunding, Toke S. Barfod, Britta Tarp and Jens Bukh.","2014","12","Christina Sølund","CS",15,TRUE,5,3,4,14,TRUE,TRUE,TRUE,1,"15",TRUE
